Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Presents 2023 Distribution Management Award to Spherity and Legisym
The Healthcare Distribution Alliance (HDA) honored Spherity and Legisym with the 2023 Distribution Management Award (DMA) in recognition of the companies’ work on a credentialing solution for Drug Supply Chain Security Act (DSCSA) Authorized Trading Partner (ATP) authentication. The award was presented during the 2023 Distribution Management Conference and Expo in Indianapolis.
HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution
A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.
HDA Unveils Redesigned HDA.org
The Healthcare Distribution Alliance (HDA) today launched a next-generation website, located at HDA.org. The website features a bright, contemporary design and intuitive functionality with member database integration and a resource-rich “Industry Hub.”
Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive Committee
The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.
HDA Statement on FDA Approval of Florida’s Prescription Drug Importation Plan
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released a statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and Cosmetic Act.